Annie Tan – Country Manager & Regional Head of Distributor Markets,…
BMS Thailand’s country manager explains the organization’s new business strategy in Thailand under her…
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Our medicines are helping millions of patients around the world in their fight against cancer, cardiovascular disease, hepatitis B, HIV/AIDS and rheumatoid arthritis.
The Bristol-Myers Squibb Foundation’s philanthropic programs seek to promote health equity and improve the health outcomes among populations disproportionately affected by serious diseases and conditions, giving new hope to some of the world’s most vulnerable people.
Over the past decade, we have delivered 14 new products to patients with serious diseases. Four of these products are biologic products. Additional biologic compounds – as well as scores of other investigational medicines – are advancing through the development pipeline. Bristol-Myers Squibb is recognized as having one of the most productive R&D pipelines in the industry.
To accelerate the discovery and development of important new therapies, we are complementing and enhancing our internal capabilities with our String of Pearls strategy of innovative alliances, partnerships and acquisitions.
As a BioPharma leader, we believe what sets us apart is our commitment to helping patients prevail over serious diseases and our focus on finding innovative medicines to combat those diseases. Generating new ideas and thinking differently are at the heart of everything we do – making a difference in the lives of patients.
Contact details
388, Exchange Tower, 17th Floor, Sukhumvit Road, Khlong Toei, Khet Khlong Toei, Bangkok, 10110, 10110
Tel: +66 02 725 1400
Website: www.bms.com
BMS Thailand’s country manager explains the organization’s new business strategy in Thailand under her…
PharmaBoardroom’s latest report: Healthcare & Life Sciences Review: Thailand is available for download…
Shinsuke Yuasa, president of Thai Otsuka discusses the importance of Thailand for Otsuka as its first overseas…
Thailand country managers from three of the world’s largest medtech firms outline the level of innovation they…
Nico Form-Zuellig, general manager of Interthai Pharmaceutical Manufacturing, shares his thoughts on the Thai…
Philippe Pedeboscq, managing director of Siemens Healthineers, shares his impressions after taking the lead of the…
Every generation of Novo Nordisk’s insulin portfolio is currently on the Thai Market and the affiliate is one of…
Nares Damrongchai has been the CEO of the Thailand Center of Excellence for Life Science (TCELS) since its…
Rajan Kalidindi, Country Manager for GE Healthcare Thailand, elaborates on the innovative solutions which drive…
The Pharmaceutical Research and Manufacturers Association (PReMA) has been a key stakeholder in promoting the value…
Selim Sezgin, country manager and managing director of Pfizer Thailand, highlights the recent transformation of the…
Sayan Roy, managing director of B. Braun Thailand, highlights the importance of the group’s 2020 Vision…
Anutin Charnvirakul, recently appointed deputy prime minister and minister of public health of Thailand, shares his…